コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ed by Western blot with pooled or individual sera.
2 ed by ADCC mediated by HIV-positive (HIV(+)) sera.
3 mbination with other epitopes, using patient sera.
4 g H7N9 and H5N1, have been detected in human sera.
5 ors by 3T3-L1 adipocytes as well as in human sera.
6 ca was 33% (14/43) from the available stored sera.
7 circulating EDA in cord blood than in adult sera.
8 p15 and/or Cp23 antigens between consecutive sera.
9 s was observed between pre- and postpandemic sera.
10 ry enriched by panning on the pool of cancer sera.
11 rocessed foods and the reactivity to patient sera.
12 nspecific background binding in CCD-positive sera.
13 lood group O allogeneic RBC in 22% of tested sera.
14 x antibodies were found in 162 of 1131 (14%) sera.
15 or GI.1 infection, as measured from archived sera.
16 0% and the other proteins with <33.3% of the sera.
17 he secretion of specific antibodies into the sera.
18 sed to evaluate immunoreactivity using human sera.
19 stress accompanied by lowered cholesterol in sera.
20 mal fusion was observed with postvaccination sera.
21 nosa BSI; 56 cases were accompanied by acute sera.
22 om ADCC-mediating antibodies present in HIV+ sera.
23 V4 to neutralization by DENV3 primary immune sera.
24 ells to ADCC mediated by HIV-positive (HIV+) sera.
25 IV-1-infected cells to ADCC mediated by HIV+ sera.
29 h peach leaf extract revealed in six patient sera a pair of bands of 10 and 16 kDa, and in nine a 16-
30 atography, we obtained from HCV-seronegative sera a purified fraction enriched in inhibitory factors.
31 the broadest reactivity with myeloma patient sera after allogeneic HSCT and that may be significantly
34 GT, but not bmGT, was detected in 71% of sera and 50% of BALF of neutropenic mice; neither was de
36 tibodies have since been isolated from human sera and associated with positive and negative outcomes
38 ication of favorable donors with potent bnAb sera and by development of improved methods for human an
39 oduct FFA]/[precursor FFA] ratios in fasting sera and clinical data from 481 individuals who particip
40 immunoassay analysis with rabbit polyclonal sera and human IgE indicated only minor differences in p
42 ndpoint titers and avidity indices of IgG in sera and IgA in tracheal, lung, and intestinal secretion
43 emained higher with IgHPolyFab in the normal sera and in IVIg, but the reverse was true when the auto
44 P) activities, were present with both immune sera and isolated MAbs, confirming the induction of nonn
48 red HLA (r = 0.40) and highest using diluted sera and SAB with 30% or less denatured HLA (r = 0.86).
49 I and C1q-SAB MFI was lowest using undiluted sera and SAB with greater than 30% denatured HLA (r = 0.
50 posure (cotinine level) in archived maternal sera and schizophrenia in offspring from a national birt
53 tudy used the Danish archived midgestational sera and their nationwide registers to search for antibo
54 easured TG level in fruit juices, beverages, sera and urine samples and reused upto 200 times over a
55 IL-6, TNF-alpha, MCP-1/CCL2 and IFN-gamma in sera, and ameliorated the organ damage of liver and kidn
56 sociated protein-like 2 (CASPR2) in maternal sera, and to relate them to subsequent psychiatric diagn
57 nsor was developed for the identification of sera antibodies (human IgG) from patients with spotted f
59 ence reaction, however two samples of paired sera are necessary to confirm the diagnosis, since using
61 hritis patients, C4d-PEDF complexes found in sera arise from the joints, as well as from other tissue
64 nant allergens were compared in CCD-positive sera before and after inhibition with a CCD inhibitor (M
68 In this study, we examined human and swine sera by swine or human TTV-specific PCRs, to determine w
69 and microarray technology, respectively, in sera collected at ages 1, 2, 3, 5, 6, 7, 10, 13, and 20
71 We quantified immunological parameters in sera collected before the SM event in cases and their in
72 hypothesis, we measured the ability of human sera collected between 1979 and 2010 to block glycan bin
74 agglutination-inhibition (HAI) assays, using sera collected from 382 individuals prior to the 2013-20
76 rried out untargeted metabolomic analysis of sera collected from female BALB/c mice experimentally in
77 ared ADCC-mediating antibodies (ADCC-Abs) in sera collected from healthy infants, children and adults
79 ducted on 3698 swine sera, including archive sera collected in 2009, as well as samples collected in
81 tion of RSV PRNT <1:200 in one-third of cord sera confirms the need to increase levels of RSV neutral
83 mimHNK-1)45 the inhibitory effect on patient sera could be improved by a factor of up to 230,000 per
85 e was changed because human, but not ferret, sera distinguish A(H1N1)pdm09 viruses isolated after 201
91 dized reagents to monitor complex polyclonal sera for neutralization activity and to characterize the
92 pteronyssinus or D. farinae were assessed in sera from 1302 house dust mite (HDM)-allergic patients l
93 d metabolomic assay was performed in fasting sera from 136 CHB patients, 104 HBV-associated cirrhosis
95 -C6 antibodies were detected in pretreatment sera from 17 of 29 (59%) subjects, whereas only 5 of 29
98 f IDV antibody titers (11.7%), while archive sera from 2009 showed statistically significant lower po
99 r binding of annexin A2 to sialostatin L2 in sera from 21 out of 23 infected patients than in sera fr
102 broadly neutralizing antibodies (bnAbs) and sera from 30 subjects with chronic clade C infections.
105 g a custom-designed proteome microarray with sera from 35 healthy US adults revealed a continuous dis
106 processing were analyzed by immunoblot with sera from 52 peanut-allergic individuals displaying diff
110 ssessed by Luminex in acute and convalescent sera from 91 EM patients, in serum and synovial fluid fr
111 s compared with that of real-time PCR, using sera from a cohort of acutely infected individuals, in a
117 her levels of EGFL7 protein are found in the sera from AML patients than in sera from healthy control
118 actors including 3D nature of embryoid body, sera from animals, and the feeder cells isolated from mo
119 On a 7,455 peptide Pf proteome array, immune sera from at least 5 out of 9 group III vaccinees recogn
121 among these species and cultivars, mainly in sera from atopic patients that react to lupin rather tha
126 Using a combination of animal models and sera from clinically well-characterized patients, we hav
127 ic activity of the formulas were tested with sera from CM-allergic patients (n = 26) in RAST-based as
128 from 21 out of 23 infected patients than in sera from control individuals was also demonstrated.
130 effect of treatment on complement activity, sera from dosed subjects were analyzed in a CP activatio
131 and aggregated ovalbumin were measured with sera from egg-allergic children and from mice sensitized
132 d the levels of IL-6 and related proteins in sera from emphysematous mice and patients were also asse
133 od group antigen (HBGA) blocking assay using sera from GII.4 and the GII.17 variant-infected patients
134 form was constructed and immunoscreened with sera from healthy (n = 49), lung cancer (LC) (n = 31) an
136 otropic reagent Urea and probing with immune sera from healthy individuals (n = 109) increased ELISA
137 to sensitize HIV-1-infected cells to ADCC by sera from HIV-1-infected individuals.IMPORTANCE HIV-1 ev
141 RNAs isolated from extracellular vesicles in sera from infected individuals may provide a new tool fo
146 ed, because AP activity is still observed in sera from MASP-1/3-deficient Malpuech-Michels-Mingarelli
147 stimulating cellular proliferation when the sera from mice are injected sc with individual liposome-
152 was established by culturing DCs with pooled sera from multiple non-small cell lung cancer (NSCLC) pa
153 2-tier test) were equivalent in identifying sera from negative-control subjects (99% and 100% specif
154 ed viruses, we tested acute and convalescent sera from nine Thai patients with PCR-confirmed DENV inf
155 We found that treatment of podocytes with sera from normoalbuminuric type 1 diabetes patients with
157 y controls, cultured in the presence of both sera from patients and mtDNA, reproduced a refractory st
158 tilized to detect HM14c10-like antibodies in sera from patients who recovered from DENV-1, infection
159 Principal component analysis of data on sera from patients with AD revealed the presence of 4 po
160 more, elevated IL-16 levels are found in the sera from patients with AIH, hepatitis B virus, hepatiti
161 Plasma exchange reduces levels of B7 in sera from patients with ALF and might be used to restore
162 sion of CTLA4 after 24-48 hours culture with sera from patients with ALF; these sera were found to ha
163 pathway activation and hemolysis induced by sera from patients with atypical hemolytic uremic syndro
165 more anti-basement membrane antibodies than sera from patients with CRSwNP and control subjects (P <
166 sing quantitative proteomics of pretreatment sera from patients with grass pollen allergy reveals tha
172 d aqueous pollen protein extract (APE) using sera from short ragweed pollen-sensitized patients.
179 d on a well-characterized panel of 279 human sera from the CDC, comparing ELISAs using these two reco
180 nked immunosorbent assay, we analyzed serial sera from the START study to decipher the various anti-A
183 A small 12-Env panel was chosen to screen sera from vaccine trials or natural-infection studies fo
184 found to improve liver glycogen storage and sera glucose level in mice expressing human AATZ mice.
185 peptides, we found that 9 of 17 (53%) paired sera had a >/=4-fold increase in antibody titer to clust
187 f enhanced ZIKV replication by dengue-immune sera have raised concerns about the role of previous DEN
188 r to characterize cross-reactive breadth for sera identified as having potent neutralization activity
189 evels of interleukin-15 present in patients' sera, immature NK cells (CD62L(+)NKG2A(+)KIR(-)) became
193 rological tests were conducted on 3698 swine sera, including archive sera collected in 2009, as well
195 cing, the large number of cancer and control sera is required to identify cancer-specific peptides wi
197 human sera, IVIg, and allograft recipients' sera, it was observed that the number of HLA-Abs was not
198 gHPolyFab and FcMonoIgG against normal human sera, IVIg, and allograft recipients' sera, it was obser
199 tients with Graves' disease, but not control sera, led to secretion of TG with an increased intrinsic
201 myosin showed IgE reactivity with 60% of the sera, lysosomal aspartic protease, and "AAEL006070-PA" (
202 e immunoreactivity of onchocerciasis patient sera (n = 152) from the Americas, West Africa, Central A
206 label-free mass spectrometry in pretreatment sera obtained from clinical responders and nonresponders
209 EBV gp350-specific IgG was detected in the sera of 17 (71%) of 24 individuals at the time of AIM an
215 t of potentiometric determination of urea in sera of apparently healthy and persons suffering from ki
216 y quantifying anti-Neu5Gc antibody levels in sera of children enrolled in 2 farm studies: the Prevent
217 bserved from HCV-infected hepatocytes and in sera of chronic HCV patients with fibrosis compared to h
220 ignificantly lower levels (P < 0.003) in the sera of HCC patients compared with healthy volunteers.
221 the formation of LVPs that circulate in the sera of HCV patients and are also produced in an in vitr
222 ification of protein and miRNA biomarkers in sera of ill children reflecting brain damage and T. gond
223 -BPA and BPA-glucuronide were quantitated in sera of individual PND 3 pups collected 1 hr postexposur
224 beta by Rickettsia-infected BMDCs and in the sera of infected mice were significantly reduced in MyD8
226 reased level of proinflammatory cytokines in sera of mice infected with the virus lacking the m20.1 a
228 s in vivo, was significantly elevated in the sera of newly diagnosed AML patients and is a strong ind
231 ulators of the serum protein patterns in the sera of patients with diffuse cutaneous systemic scleros
232 he head and neck SCCs, and EVs isolated from sera of patients with SCC were enriched in Dsg2 C-termin
237 tained and even enhanced its presence in the sera, over ten years post infection; the prevalence of o
239 ed susceptibility to neutralization by human sera pooled from approximately 60 to 80 North American d
240 er cancer associations differed by hepatitis sera-positivity in nested analyses for a subset of cases
245 ody competition studies revealed that immune sera raised to high-molecular-weight Delta123 was poly s
247 epitope specificity between BM and maternal sera ranging from only 13% of sample pairs sharing at le
249 and 217 MGBs were identified from TD and ASD sera respectively, of which 74 proteins were specially i
258 ence of heterologous and autologous post-AIT sera significantly reduced the allergic airway inflammat
260 ways were simultaneously repressed by cancer sera, suggesting that the attenuated NF-kappaB and STAT3
261 uppression withdrawal were also evaluated in sera taken at predetermined intervals during immunosuppr
262 Fc established allergen-specific artificial sera that showed comparable results for more than 20 all
266 re was a good correlation (r = 0.99) between sera urea values obtained by reference method (Enzymic c
267 nd food allergen components were analyzed in sera using allergen microarray and compared between 5 Fr
271 Furthermore, the autoreactive capacity of CU sera was evaluated and urticaria-related symptoms were a
273 tion of the FcgammaRI reporter by survivors' sera was substantially high one year after acute infecti
274 e site-specific antibodies in vaccine immune sera, we demonstrated that vaccination elicited function
278 ins, VRC01 concentrations from participants' sera were found to avidly capture HIV virions and to med
279 ture with sera from patients with ALF; these sera were found to have increased concentrations of solu
285 ere tested for ZIKV-specific antibodies, and sera were screened for other congenital infections.
286 poallergenic Cyp c 1 mutant mouse and rabbit sera were tested for their ability to inhibit IgE recogn
289 e neutralization-response profile of vaccine sera will be relative to that of sera from infected indi
290 Bacterial inoculum was measured in patient sera with elevated (n = 8) or low (n = 8) IL-10 using a
291 enic maps derived from human postvaccination sera with H1 influenza preexposure also correlated poorl
295 so correlated poorly with those derived from sera with neither H1 nor type B influenza preexposure, a
296 wed good correlation with those derived from sera with neither H1 nor type B influenza preexposure.
297 enic maps derived from human postvaccination sera with only type B influenza preexposure consistently
298 ype H1N1 viruses, COBRA HA antigens elicited sera with the broadest HAI reactivity against multiple a
299 of an immunoglobuline preparation and three sera with unfolded CMV antigens enhanced clearly the neu
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。